>
pdufa.bio

A-101

Updated ยทnext FDA decision on the calendar

A-101 is a Aclaris Therapeutics, Inc. program. Every date links its source.

ACRS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Aclaris Therapeutics, Inc. (ACRS). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Aug 2026ACRS

Questions

When is A-101's next FDA decision or readout?

No upcoming catalyst is on our calendar for A-101; no FDA decisions are on record below.

What happened at A-101's most recent FDA decision?

No FDA decision for A-101 is in our archive yet.

Who makes A-101?

Aclaris Therapeutics, Inc. (ACRS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.